Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy - Elisabeth Bergen - Books - Springer Basel - 9783034803182 - February 25, 2013
In case cover and title do not match, the title is correct

Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy 2011 edition

Elisabeth Bergen

Price
A$ 282.49

Ordered from remote warehouse

Expected delivery Dec 18 - 31
Christmas presents can be returned until 31 January

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy 2011 edition

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors.

110 pages, biography

Media Books     Paperback Book   (Book with soft cover and glued back)
Released February 25, 2013
ISBN13 9783034803182
Publishers Springer Basel
Pages 110
Dimensions 155 × 235 × 7 mm   ·   181 g
Editor Bartsch, Rupert
Editor Grunt, Thomas W.
Editor Sibilia, Maria
Editor Zielinski, Christoph C.

See all of Elisabeth Bergen ( e.g. Paperback Book )